TisN0M1 sigmoid colon cancer: A case report

Annals of Coloproctology

Volumn 30, Issue 3, 2014, Pages 141-146

  Lee, Kyung Ha ^a   Kim, Jin Su ^a   Cheon, Kwang Sik ^a   Song, In Sang ^a   Kang, Dae Young ^a   Kim, Ji Yeon ^a  

^a Chungnam National University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Carcinoma in situ; Colon neoplasms; Lymphatic metastasis

Indexed keywords

CYTOKERATIN 20; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CARCINOMA IN SITU; CASE REPORT; COLON ADENOCARCINOMA; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; LAMINA PROPRIA; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MEDICAL HISTORY; MULTIMODALITY CANCER THERAPY; PARAAORTIC LYMPH NODE; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; SIGMOID; SIGMOID COLON CANCER; TISSUE DIFFERENTIATION; TREATMENT REFUSAL;

EID: 84903883734     PISSN: 22879714     EISSN: 22879722     Source Type: Journal    
DOI: 10.3393/ac.2014.30.3.141     Document Type: Article

References (6)

1. Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, et al. Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology 2005;52:1688-91.
2. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004;54:295-308. (Pubitemid 40073988)
3. Oien KA, Dennis JL. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling. Ann Oncol 2012;23 Suppl 10:x271-7.
4. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
5. Park SJ, Kim JH, Choi CI, Kim DH, Jeon TY, Kim DH. Multiple bone metastases after curative resection of early gastric cancer confined to mucosa without lymph node metastasis. Korean J Clin Oncol 2013;9:66-9.
6. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-12.